domingo, 26 de mayo de 2024

What clinical real-world data can deliver By Jenna PhillipsMay 22, 2024 New drugs are entering the clinic faster than ever. The FDA’s Breakthrough Therapy designation program is an example of regulatory innovation that helps speed drugs to market, writes Boston-based health and life sciences consultant Jenna Phillips — but it also means that there’s less time to train clinicians on best practices with a new therapy. In a new First Opinion, Phillips argues that real-world clinical data can offer insights about how to best use new medicines. It can help pinpoint clinician and patient experiences with new drugs: Real-world data on GLP-1 weight loss drugs, for example, shows patients present to the emergency department with side effects like gastrointestinal distress. Read more about how these kind of insights could help health workers improve care.

No hay comentarios: